ARCHIVES

Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial

This article is from The Cancer Letter archive.

Vol. 15 No. 43 | November 10, 1989

Download PDF Visit The Full Archive

Related Articles

Cancer Advocacy: Deal Returns $3M to Office of Women’s Health, Spends $3.5M On Workshops

August 1, 1997

Four New Program Announcements For BRMP Trials Issued

October 22, 1982

New Treatment Modalities For Endometrial Cancer

March 26, 2004

FDA Warns of Lymphoma Risk Associated With Breast Implants

January 28, 2011

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

Funding opportunities listed.

March 12, 2004